INVO Fertility, Inc. (IVF)
NASDAQ: IVF · Real-Time Price · USD
1.390
-0.110 (-7.33%)
At close: Jun 22, 2026, 4:00 PM EDT
1.440
+0.050 (3.60%)
After-hours: Jun 22, 2026, 7:40 PM EDT
Company Description
INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients.
It operates through Fertility Clinic Services and INVOcell Device segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body.
It also operates fertility clinics, including INVO Centers. The company was formerly known as NAYA Biosciences, Inc. and changed its name to INVO Fertility, Inc. in April 2025.
INVO Fertility, Inc. was founded in 2007 and is based in Sarasota, Florida.
INVO Fertility, Inc.
| Country | United States |
| Founded | 2007 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 42 |
| CEO | Steven Shum |
Contact Details
Address: 5582 Broadcast Court Sarasota, Florida 34240 United States | |
| Phone | 978 878 9505 |
| Website | invofertility.com |
Stock Details
| Ticker Symbol | IVF |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001417926 |
| CUSIP Number | 44984F609 |
| ISIN Number | US44984F8804 |
| Employer ID | 20-4036208 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Steven M. Shum | Chief Executive Officer and Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 22, 2026 | 8-K | Current Report |
| Jun 22, 2026 | 10-Q | Quarterly Report |
| Jun 16, 2026 | 8-K | Current Report |
| Jun 12, 2026 | PRE 14A | Other preliminary proxy statements |
| Jun 12, 2026 | 10-K/A | [Amend] Annual report |
| Jun 2, 2026 | 8-K | Current Report |
| Jun 2, 2026 | 10-K | Annual Report |
| Jun 2, 2026 | 8-K | Current Report |
| May 18, 2026 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB |
| May 15, 2026 | SCHEDULE 13G/A | Filing |